Acura Pharmaceuticals reported 523K in Selling and Administration Expenses for its second fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Selling And Administration Expenses Change
Acelrx Pharmaceuticals ACRX:US $ 7.34M 1.38M
Acura Pharmaceuticals ACUR:US 523K 138K
Intra Cellular Therapies ITCI:US $ 75.46M 4.22M
Johnson & Johnson JNJ:US $ 5.94B 1.22B
Nektar Therapeutics NKTR:US $ 27.34M 4.8M
Rigel Pharmaceuticals RIGL:US $ 27.4M 2.89M
Shionogi 4507:JP 25.23B 2.94B
Teva Pharmaceutical TEVA:IT 819M 39M
Xeris Pharmaceuticals Inc XERS:US $ 27.31M 24.67M